- Home
- RRGB vs CTOR Comparison
RRGB vs CTOR Comparison
Compare RRGB & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- CTOR
- Stock Information
- Founded
- RRGB 1969
- CTOR 2021
- Country
- RRGB United States
- CTOR United States
- Employees
- RRGB N/A
- CTOR N/A
- Industry
- RRGB Restaurants
- CTOR
- Sector
- RRGB Consumer Discretionary
- CTOR
- Exchange
- RRGB Nasdaq
- CTOR NYSE
- Market Cap
- RRGB 88.7M
- CTOR 63.7M
- IPO Year
- RRGB 2002
- CTOR N/A
- Fundamental
- Price
- RRGB $5.65
- CTOR $1.94
- Analyst Decision
- RRGB Strong Buy
- CTOR Buy
- Analyst Count
- RRGB 4
- CTOR 2
- Target Price
- RRGB $11.88
- CTOR $6.00
- AVG Volume (30 Days)
- RRGB 350.7K
- CTOR 2.7M
- Earning Date
- RRGB 08-21-2025
- CTOR 08-11-2025
- Dividend Yield
- RRGB N/A
- CTOR N/A
- EPS Growth
- RRGB N/A
- CTOR N/A
- EPS
- RRGB N/A
- CTOR N/A
- Revenue
- RRGB $1,252,370,000.00
- CTOR N/A
- Revenue This Year
- RRGB N/A
- CTOR N/A
- Revenue Next Year
- RRGB N/A
- CTOR N/A
- P/E Ratio
- RRGB N/A
- CTOR N/A
- Revenue Growth
- RRGB N/A
- CTOR N/A
- 52 Week Low
- RRGB $2.50
- CTOR $0.55
- 52 Week High
- RRGB $7.05
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- RRGB 56.69
- CTOR N/A
- Support Level
- RRGB $5.88
- CTOR N/A
- Resistance Level
- RRGB $6.89
- CTOR N/A
- Average True Range (ATR)
- RRGB 0.42
- CTOR 0.00
- MACD
- RRGB -0.05
- CTOR 0.00
- Stochastic Oscillator
- RRGB 61.14
- CTOR 0.00
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.